Cortellis Deals Intelligence
Negotiate your best deal with insights from pharma deals intelligence
Inform your pharma deal making with trusted data and insights
Evaluate life sciences biopharma deals to find the best partner, empower negotiations and fuel company growth. Assess comparable deal terms, evaluate financials and perform due diligence for in- or out-licensing opportunities with comprehensive pharma deals intelligence.
Broad and deep coverage of global pharma deals, coupled with artificial intelligence enabled analytics
Leverage early pipeline intel
Never miss emerging competitors or pharma licensing opportunities with comprehensive coverage of early-phase assets and the start-up companies behind them.
Find answers in the data
Forecast deal values and success with our AI-based predictive deals analytics tool, which is far more accurate than conventional averages-based benchmarking.
Time-saving trends visualizations
Easily create deal activity and due diligence reports for internal and/or partnering meetings with key deal trends graphs.
Position your pharma deals to achieve maximum ROI
Find your ideal partner
Identify in-license opportunities based on your ideal candidate’s characteristics or identify potential pharma out-licensing partners based on experience in the field and/or portfolio gaps. Further explore potential partners’ deal history including payment terms.
Benchmark asset values and prepare for negotiations
Find comparable deals in a few clicks, and access complete contracts, including unredacted versions, to better understand your potential partner’s past deal terms. Create and export your own custom analyses and financial summaries to rapidly understand deal values.
Accurately forecast asset value
Predict potential deal sizes at each stage of drug development using our first-in-class AI-based deal value predictive analytics, and uncover how likely it would be for a drug to progress to the next phase of development if you were to partner.
Make high-value pharma deals intelligence faster
Confidently assess comparable pharma deal terms, evaluate financials and perform due diligence with comprehensive pharma deals intelligence solutions.
Identify the best time to partner
Determine the optimal time to partner an asset based on a comprehensive and accurate understanding of the competition, existing pharma deals, and reliable forecasting.
Negotiate the most lucrative deal
Explore granular deal size and payment terms by phase/stage of development within deal reports and contracts.
Perform due diligence within minutes
Save hours of time by exploring aggregated, top pharma and multiyear deal trends by therapy area or indication.
